期刊文献+

急性白血病患者血中α-羟丁酸脱氢酶与乳酸脱氢酶的检测及临床意义 被引量:7

Detection and clinical significance of serumα-hydroxybutyrate dehydrogenase and lactic dehydrogenase in patients with acute leukemia
在线阅读 下载PDF
导出
摘要 目的:探讨急性白血病(AL)患者血中α-羟丁酸脱氢酶(α-HBDH)与乳酸脱氢酶(LDH)的检测及临床意义。方法:选取入住本院的急性白血病患者82例作为AL组,另选取健康体检者65例作为对照组,检测两组研究对象的α-HBDH、LDH含量变化并进行比较。结果:AL初发或复发患者治疗前和对照组α-HBDH、LDH含量相比,差异有统计学意义(P<0.05);且其治疗前α-HBDH、LDH含量明显升高。治疗后,完全缓解者、部分缓解者、未缓解者α-HBDH、LDH含量比较,差异有统计学意义(P<0.05);完全缓解者、部分缓解者治疗前后α-HBDH、LDH含量比较,差异均有统计学意义(P<0.05);且治疗后α-HBDH、LDH含量均明显下降,未缓解者治疗前后α-HBDH、LDH含量比较,差异无统计学意义(P>0.05);AL复发患者复发前后α-HBDH、LDH含量比较,差异均具有统计学意义(P<0.05);复发后α-HBDH、LDH含量均明显升高。结论:动态监测血清α-HBDH和LDH的变化对AL患者的病情变化、疗效和判断预后具有重要的临床指导意义。 Objective: To investigate the detection and clinical significance of serum α-hydroxybutyrate dehydrogenase and lactic dehydrogenase in patients with acute leukemia. Methods:82 patients with acute leukemia as AL group were selected as AL group, and 65 healthy volunteers were selected as control group, content of α -HBDH, LDH were compared between the two groups in the. Results:There was significant difference between the AL primary or recurrent patients before the treat- ment and the control group in the content of α-HBDH, LDH(P〈0.05), and the content of α -HBDH, LDH significantly in creased in the AL primary or recurrent patients before the treatment. After the treatment, there were statistically significant difference in the content of α-HBDH, LDH among the complete remission group, partial remission group, and no remission group(P〈0.05), there were also statistically significant difference in the content of α-HBDH, LDH before and after the treat- ment between the complete remission group and the partial remission group(P〈0.05), the content of α -HBDH, LDH bothdecreased in the two group, there was no statistically significant difference in the no remission group before and after the treat- ment(P〉0.05), there was statistically significant difference in the content of α -HBDH, LDH between the AL patients before the recurrent and after(P〈0.05). Conclusion: The dynamic detection of the levels of serum α-HBDH and LDH has important clinical significance and it may contribute to observe the changes of diseases process in AL patients, curative effect and progno- sis assessment.
出处 《海南医学院学报》 CAS 2014年第12期1742-1744,共3页 Journal of Hainan Medical University
基金 首都医学发展基金(2012-1098)~~
关键词 白血病 急性 Α-羟丁酸脱氢酶 乳酸脱氢酶 Leukemia Acute α-hydroxybutyrate dehydrogenase Lactic dehydrogenase
作者简介 张越(1981-),女,硕士,电话:13552370700,电子邮箱:zhangyue6354@163.com. [通讯作者]周合冰(1967-),女,硕士,主任医师,主要从事血液病的诊断及治疗工作。
  • 相关文献

参考文献10

二级参考文献41

共引文献98

同被引文献54

  • 1汪宝贞,余永卫,周少雄,张小青.急性白血病患者血脂及乳酸脱氢酶变化的临床研究[J].白血病.淋巴瘤,2005,14(4):228-229. 被引量:12
  • 2H a n k e M , H o f f m a n n I , Christophis C , et al. Differences betweenhealthy hematopoietic progenitors a n d leukemia cells with respect toC D 4 4 mediated rolling versus adherence behavior on hyaluronic acidcoated surfaces[J] . Biomaterials, 2 0 1 4 , 3 5 ( 5 ) :1 4 1 1 - 1 4 1 9 .
  • 3V a n d e n A n c k e r W , Westers T M , de L e e u w D C , et al. A threshold of1 0 % for myeloperoxidase b y flow cytometry is valid to classify acuteleukemia of am b i g u o u s a n d myeloid origin [J]. Cytometry B Clin Cytom,2 0 1 3 , 8 4 ( 2 ) :1 1 4 - 1 1 8 .
  • 4M a c h a d o - Neto J A , de M e l o C a m p o s P, Favaro P, et al. Stathmin 1 isinvolved in the highly proliferative phenotype of high - risk myelodysplastics y n dromes a n d acute leukemia cells [J]. L e u k R e s , 2 0 1 4 , 3 8( 2 ) :2 5 1 - 2 5 7 .
  • 5VardimanJ. T h e classification of M D S : F r o m F A B to W H O a n d b e yond[J]. L e u k R es, 2 0 1 2 , 3 6 ( 1 2 ) :1 4 5 3 - 1 4 5 8 .
  • 6Veat c h J R , S a n d h u V , B e c k e r P S, et al. T h e N C I c o m m o n toxicity criteriaa n d treatment - associated mortality in acute myeloid leukemia.[J]. Blood, 2 0 1 3 , 1 2 2 ( 2 ) :2 9 3 - 2 9 4 .
  • 7徐数娜,张旭辉,张日,等. 急性白血病患者血脂、血糖及蛋白检测的临床意义[J] . 中华临床医师杂志(电子版),2 0 1 3 ,(9 ) :4089- 4 0 9 0 .
  • 8Quintas - C a r d a m a A , Kantarjian H , Pierce S , et al. Prognostic m o d e lto identify patients with myelofibrosis at the highest risk of transformationto acute myeloid L e u k e m i a [J]. Clin L y m p h o m a M y e l o m a L e u k ,2 0 1 3 , 1 3 ( 3 ) :3 1 5 - 3 1 8 .
  • 9M a t s u m o t o K , Y a m a m o t o W , O g u s a E , et al. Impact of pretransplants e r u m ferritin on outc o m e in adult patients receiving cord blood transplantfor acute leukemia [J]. L e u k L y m p h o m a , 2 0 1 4 , 5 5 ( 2 ) : 4 6 0 -461.
  • 10Shimizu H , H a n d a H , H a t s u m i N , et al. Distinctive disease subgroupsaccording to differentiation stages in adult patients with T - cell acutelymphoblastic leukemia[J] . E u r J H a e m a t o l , 2 0 1 3 , 9 0 ( 4 ) :3 0 1 - 307.

引证文献7

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部